Vibrotactile stimulation may improve pain, fatigue, and sleep quality in individuals with fibromyalgia.
Reductions in pain scores in patients with fibromyalgia who used a minimally invasive Angel Touch device for 8 weeks were found in meta-analyses to be comparable to those reported by patients treated with drugs for the condition.
Women with fibromyalgia may be more likely to have comorbid depression and arthritis compared with men.
Interactions between patients and clinicians involving information, identification of providers who fit patients’ needs, and realization of shared responsibilities may contribute to the development of effective relationships between patients with fibromyalgia and health care providers.
There may be substantial disparity between diagnoses of fibromyalgia based on criteria vs International Classification of Disease standards.
There is disagreement between clinical diagnosis and criteria-based diagnosis of fibromyalgia.
Smoking tobacco is a risk factor for cognitive dysfunction in patients with fibromyalgia.
For women with fibromyalgia, comorbid posttraumatic stress disorder may contribute to blunted cardiovascular reactivity to stress.
Increases in stimulation intensity for transcutaneous electrical nerve stimulation may benefit women with fibromyalgia-related pain, particularly older women and women with anxiety.
In a randomized control trial, researchers found that internet-delivered exposure therapy was more cost-effective for patients with fibromyalgia than a waitlist control, which did not involve any treatment during the experimental phase of the study.